Therapeutic Asset Ratings
4,337 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
CEFACLOR ANHYDROUS
Biliary Atresia
Children's Hospital of Fudan University
N/A
D
(30)
CEFACLOR ANHYDROUS
Cholangitis
Children's Hospital of Fudan University
N/A
D
(30)
Cefazolin
Bariatric Surgery
Hospital dos Lusíadas
N/A
D
(30)
Cefazolin
Opioid Free Anesthesia
Hospital dos Lusíadas
N/A
D
(30)
Cefazolin
Postoperative Pain
Hospital dos Lusíadas
N/A
D
(30)
CEFOXITIN
Bowel Cancer
Egymedicalpedia
N/A
D
(30)
CEFOXITIN
Colonic Polyp
Egymedicalpedia
N/A
D
(30)
CEFOXITIN
IBS - Irritable Bowel Syndrome
Egymedicalpedia
N/A
D
(30)
Ceftriaxone
Hypertension, Portal
Second Affiliated Hospital, School of Medicine, Zhejiang University
N/A
D
(30)
Ceftriaxone
Variceal Hemorrhage
Second Affiliated Hospital, School of Medicine, Zhejiang University
N/A
D
(30)
CEFUROXIME
Cholangitis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
N/A
D
(30)
Cetuximab
Colorectal Cancer Liver Metastases
Fudan University
N/A
D
(30)
Cetuximab
ctDNA Genotype
Peking University
N/A
D
(30)
Cetuximab
Digestive System Neoplasm
Institute of Oncology Ljubljana
N/A
D
(30)
Cetuximab
Exon Mutation
Peking Union Medical College Hospital
N/A
D
(30)
Cetuximab
Failed From Standard Treatment
Peking University
N/A
D
(30)
Cetuximab
Thyroid Gland Papillary Carcinoma
Peking Union Medical College Hospital
N/A
D
(30)
cg-102-12c
Hepatocellular Carcinoma
Zhejiang University
N/A
D
(30)
Chamomile
Neurodegenerative Disease
Jinnah Postgraduate Medical Centre
N/A
D
(30)
CHARCOAL ACTIVATED
Breast Cancer
Fujian Medical University Union Hospital
N/A
D
(30)
CHARCOAL ACTIVATED
Neoadjuvant Therapy
Fujian Medical University Union Hospital
N/A
D
(30)
CHG0521
Squamous Cell Carcinoma
Guangzhou University of Traditional Chinese Medicine
N/A
D
(30)
Chiglitazar
Cirrhosis Of Liver
Beijing Friendship Hospital
N/A
D
(30)
Chi-Gvm
Peripheral T-Cell Lymphoma, Not Otherwise Specified
The First Affiliated Hospital with Nanjing Medical University
N/A
D
(30)
Chimeric Antigen Receptor Modified T Cells Infusion
Acute Lymphoblastic Leukemia, Adult
Institute of Hematology & Blood Diseases Hospital, China
N/A
D
(30)
Showing 726 to 750 of 4,337 assets
Previous
Page 30 of 174
Next